» Articles » PMID: 29114454

Visual Masking & Schizophrenia

Overview
Specialty Psychology
Date 2017 Nov 9
PMID 29114454
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Visual masking is a frequently used tool in schizophrenia research. Visual masking has a very high sensitivity and specificity and masking paradigms have been proven to be endophenotypes. Whereas masking is a powerful technique to study schizophrenia, the underlying mechanisms are discussed controversially. For example, for more than 25 years, masking deficits of schizophrenia patients were mainly attributed to a deficient magno-cellular system (M-system). Here, we show that there is very little evidence that masking deficits are magno-cellular deficits. We will discuss the magno-cellular and other approaches in detail and highlight their pros and cons.

Citing Articles

Reduced Visual Function in Schizotypal Traits: An Exploratory Study.

Llapashtica E, Barbur J, Haenschel C Schizophr Bull. 2025; 51(Supplement_2):S205-S213.

PMID: 40037828 PMC: 11879504. DOI: 10.1093/schbul/sbae049.


Continuous temporal integration in the human visual system.

Deodato M, Melcher D J Vis. 2024; 24(13):5.

PMID: 39636722 PMC: 11622157. DOI: 10.1167/jov.24.13.5.


Visual Neurophysiological Biomarkers for Patient Stratification and Treatment Development Across Neuropsychiatric Disorders.

Martinez A, Hillyard S, Javitt D Adv Neurobiol. 2024; 40:757-799.

PMID: 39562463 DOI: 10.1007/978-3-031-69491-2_25.


Pre-stimulus EEG phase coherence predicts visual target detection failures in schizophrenia: A pilot study.

Reavis E, Wynn J, Green M Schizophr Res. 2024; 272:112-119.

PMID: 39214021 PMC: 11663490. DOI: 10.1016/j.schres.2024.08.016.


Faster bi-stable visual switching in psychosis.

Killebrew K, Moser H, Grant A, Marjanska M, Sponheim S, Schallmo M Transl Psychiatry. 2024; 14(1):201.

PMID: 38714650 PMC: 11076514. DOI: 10.1038/s41398-024-02913-z.


References
1.
Schechter I, Butler P, Silipo G, Zemon V, Javitt D . Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophr Res. 2003; 64(2-3):91-101. DOI: 10.1016/s0920-9964(03)00008-2. View

2.
Keri S . The magnocellular pathway and schizophrenia. Vision Res. 2008; 48(9):1181-2. DOI: 10.1016/j.visres.2007.11.021. View

3.
Butler P, Harkavy-Friedman J, Amador X, Gorman J . Backward masking in schizophrenia: relationship to medication status, neuropsychological functioning, and dopamine metabolism. Biol Psychiatry. 1996; 40(4):295-8. DOI: 10.1016/0006-3223(96)00007-8. View

4.
Keri S, Kelemen O, Benedek G, Janka Z . Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med. 2001; 31(5):915-22. DOI: 10.1017/s0033291701004068. View

5.
Butler P, DeSanti L, Maddox J, Harkavy-Friedman J, Amador X, Goetz R . Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology. Schizophr Res. 2002; 59(2-3):199-209. DOI: 10.1016/s0920-9964(01)00341-3. View